The researchers from the University of Alabama.

Related StoriesSt. Michael's Hospital study finds that cholesterol-reducing diet also lowers blood pressureTobacco use continues to be a top threat to health and economic well-being of people in ChinaPublic health policies targeting smokers could possibly have opposite effect, research findsThe researchers found that the combination increased by almost 5 situations the presence of artery lesions, compared to mice breathing regular air and feeding on a normal diet. Professionals say artery lesions certainly are a common problem in large smokers and a sign of advancing coronary disease.

Tijssen, Ph.D., A. Marco Alings, M.D., Hans L. Hillege, M.D., Johanna A. Bergsma-Kadijk, M.Sc., Jan H. Cornel, M.D., Otto Kamp, M.D., Raymond Tukkie, M.D., Hans A. Bosker, M.D., Dirk J. Van Veldhuisen, M.D., and Maarten P. Van den Berg, M.D. For the Competition II Investigators: Lenient versus Strict Rate Control in Sufferers with Atrial Fibrillation Atrial fibrillation is not a benign condition.1 It may cause symptoms and is associated with stroke and heart failure. Previous studies established that the rates of complications and loss of life were similar in sufferers with atrial fibrillation receiving rate-control therapy and in those receiving rhythm-control therapy.2,3 Therefore, price control has become front-line therapy in the management of atrial fibrillation.Tijssen, Ph.D., A. Marco Alings, M.D., Hans L. Hillege, M.D., Johanna A. Bergsma-Kadijk, M.Sc., Jan H. Cornel, M.D., Otto Kamp, M.D., Raymond Tukkie, M.D., Hans A. Bosker, M.D., Dirk J. Van Veldhuisen, M.D., and Maarten P. Van den Berg, M.D. For the Competition II Investigators: Lenient versus Strict Rate Control in Sufferers with Atrial Fibrillation Atrial fibrillation is not a benign condition.1 It may cause symptoms and is associated with stroke and heart failure. Previous studies established that the rates of complications and loss of life were similar in sufferers with atrial fibrillation receiving rate-control therapy and in those receiving rhythm-control therapy.2,3 Therefore, price control has become front-line therapy in the management of atrial fibrillation.